NYSEARCA:LABU
LABU ETF News
$99.81
+8.94 (+9.84%)
At Close: May 01, 2024
Breakouts Everywhere As Buffett Moves To Record High $157 Billion Cash
01:19pm, Monday, 06'th Nov 2023
Warren Buffett's Berkshire Hathaway has reached record-high levels of cash, with $157 billion on hand, exceeding Disney's market capitalization. The last time Buffett held record cash levels was in la
LABU And LABD: Another Attractive Double-Short Pairs Trade
04:50pm, Friday, 29'th Sep 2023
Pairing Direxion Daily's S&P Biotech Bull 3X Shares ETF with their S&P Biotech Bear 3X Shares ETF produces a low volatility couple. Shorting both assets is attractive because leveraged assets erode ov
LABU: A Levered ETF Doomed From The Start
01:08pm, Sunday, 20'th Aug 2023
The Direxion Daily S&P Biotech Bull 3x Shares ETF (LABU) is a high-risk, leveraged ETF that aims to yield three times the performance of the S&P Biotechnology Select Industry Index. The biotech sector
10 Most-Heavily Traded ETFs of the Last Three Months
01:15pm, Monday, 10'th Jul 2023
High trading volume indicates high liquidity, which is a key characteristic of ETFs.
LABU: 2 Requirements For Making Money In This Leveraged Biotech Fund
10:00am, Tuesday, 30'th May 2023
LABU is a 3X leveraged fund that has disappointed the biotech bulls. The sector looks beaten and perhaps cheap relative to long-term prospects. LABU can work for medium term returns if two requirement
Top Performing Leveraged/Inverse ETFs: 05/07/2023
04:43pm, Wednesday, 10'th May 2023
Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
5 Leveraged/Inverse ETFs That Gained Double Digits in April
12:57pm, Tuesday, 02'nd May 2023
The month of April was marked by huge volatility. Though recession fears continued to weigh on investors sentiment, cooling inflation and better-than-expected earnings drove the stocks higher.
5 Best Inverse/Leveraged ETFs of Last Week
09:09am, Tuesday, 25'th Apr 2023
Wall Street offered a flat performance last week.
Leveraged Biotech ETFs: Hold LABU, Sell LABD
02:13pm, Wednesday, 19'th Apr 2023
SPDR® S&P Biotech ETF, the Biotechnology Select Industry Index ETF, has an extreme short interest of 51.16%. XBI is in an uptrend since May-June 2022. Direxion Daily S&P Biotech Bull 3X Shares ETF, t
Want Diversified Upside in Biotechnology? Check out LABU
09:01am, Wednesday, 22'nd Mar 2023
Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility. This ETF attempts to mimic 3X the one-d
LABU: Leveraged Biotech ETF Review
06:20pm, Tuesday, 31'st Jan 2023
Biotech stocks have pulled back and offer better risk to reward for investors, Direxion Daily S&P Biotech Bull 3x Shares ETF is a popular way to trade them. M&A is likely to drive prices for mid-cap a
10 Most-Heavily Traded ETFs of Fourth-Quarter 2022
03:05pm, Wednesday, 21'st Dec 2022 Zacks Investment Research
Thee ETF industry is seeing explosive growth, piling up huge assets amid the stock market turmoil. This has resulted in enough liquidity, with most of the ETFs trading at extremely higher volumes.
Top Performing Leveraged/Inverse ETFs: 12/04/2022
06:59pm, Wednesday, 07'th Dec 2022
Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Best Inverse/Leveraged ETFs of Last Week
01:00pm, Monday, 05'th Dec 2022 Zacks Investment Research
Last week was marked with record Cyber Monday online shopping, Fed cues of slower rate hike and upbeat U.S. jobs data.
Best Inverse/Leveraged ETFs of Last Week
09:02am, Monday, 05'th Dec 2022
Last week was marked with record Cyber Monday online shopping, Fed cues of slower rate hike and upbeat U.S. jobs data.